Legend Biotech (LEGN) Debt to Equity (2021 - 2025)
Legend Biotech (LEGN) posted Debt to Equity of $0.3 for Q1 2025, up 3.78% on a QoQ basis from $0.29 in Q4 2024, and up 22.1% year-over-year from $0.25 in Q1 2024.
Legend Biotech (LEGN) has 5 years of Debt to Equity data on file, last reported at $0.3 in Q1 2025.
- In Q1 2025, Debt to Equity rose 22.1% year-over-year to $0.3; the TTM figure through Mar 2025 stood at $0.3 (up 22.1% YoY), while the FY2024 annual figure was $0.29, up 28.76% from the prior year.
- Debt to Equity rose to $0.3 in Q1 2025, from $0.29 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.41 in Q1 2023 and bottomed at $0.05 in Q2 2021.
- A 5-year average of $0.24 and a median of $0.25 in 2024 frame the typical range for Debt to Equity.
- Annual changes were most pronounced in 2023 — Debt to Equity jumped 138.08% — and 2024, when it slumped 39.56%.
- Year by year, Debt to Equity stood at $0.16 in 2021, then surged by 122.9% to $0.35 in 2022, then slumped by 35.87% to $0.22 in 2023, then increased by 28.76% to $0.29 in 2024, then rose by 3.78% to $0.3 in 2025.
- The last three Debt to Equity figures came in at $0.3 (Q1 2025), $0.29 (Q4 2024), and $0.27 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.29 |
| Sep 30, 2024 | 0.27 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.19 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.35 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.16 |
| Sep 30, 2021 | 0.31 |
| Jun 30, 2021 | 0.05 |